Vanguard Personalized Indexing Management
FULC icon

Vanguard Personalized Indexing Management’s Fulcrum Therapeutics FULC Stock Holding History

Vanguard Personalized Indexing Management’s Portfolio FULC Stock Details FULC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$55.8K Sell
15,253
-887
-5% -$5.4K ﹤0.01% 2129
2026
Q1 		$124K Buy
16,140
+2,982
+23% +$27.7K ﹤0.01% 1924
2025
Q4 		$149K Sell
13,158
-10
-0.1% -$102 ﹤0.01% 1765
2025
Q3 		$121K Buy
13,168
+225
+2% +$1.63K ﹤0.01% 1791
2025
Q2 		$89K Buy
12,943
+2,677
+26% +$14.3K ﹤0.01% 1758
2025
Q1 		$29.6K Buy
+10,266
New +$37.7K ﹤0.01% 1729

Other funds holding FULC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Personalized Indexing Management's FULC Position: Q2 2026 in Review

Vanguard Personalized Indexing Management reduced its Fulcrum Therapeutics (FULC) stake by 5.5% in Q2 2026, selling an estimated $5.4K and leaving 15,253 shares worth $55.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2129.

Vanguard Personalized Indexing Management first reported a position in FULC in Q1 2025 and has held it in 6 quarters since. The position peaked at $149K in Q4 2025. 155 funds tracked by Wall St. Rank hold FULC as of Q2 2026.

  • Vanguard Personalized Indexing Management held 15,253 shares of Fulcrum Therapeutics worth $55.8K as of Q2 2026.
  • Vanguard Personalized Indexing Management sold 887 Fulcrum Therapeutics shares in Q2 2026, an estimated $5.4K.
  • Fulcrum Therapeutics made up ﹤0.01% of Vanguard Personalized Indexing Management's portfolio in Q2 2026, its #2129 holding.
  • Vanguard Personalized Indexing Management first reported a position in Fulcrum Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • Vanguard Personalized Indexing Management's Fulcrum Therapeutics position peaked at $149K in Q4 2025.
  • 155 funds tracked by Wall St. Rank held Fulcrum Therapeutics as of Q2 2026.

Based on Vanguard Personalized Indexing Management's 13F filing for Q2 2026, filed 11 Aug 2026.